0 items USD 0.00Search
Your search for "ark patent intelligence caspofungin patent extension data exclusivity expiry snapshot 51" gave back 221159 results.
Caspofungin is a new class of antifungal drugs called echinomycin. It acts by inhibiting the enzyme-β-D-glucan synthase, thereby interfering with the...
Catalog:
MRRPB5
May 2023
Price: USD 4,900.00
Caspofungin is a new class of antifungal drugs called echinomycin. It acts by inhibiting the enzyme-β-D-glucan synthase, thereby interfering with the...
Catalog:
LPI
January 2023
Price: USD 3,660.00
Caspofungin acetate for injection is an echinocandin antifungal indicated in adults and pediatric patients (3 months of age and older) for: ...
Catalog:
LPI
February 2023
Price: USD 3,660.00
Caspofungin acetate for injection is an echinocandin antifungal indicated in adults and pediatric patients (3 months of age and older) for: ...
Catalog:
GIR
January 2023
Price: USD 3,480.00
Caspofungin is a new class of antifungal drugs called echinomycin. It acts by inhibiting the enzyme-β-D-glucan synthase, thereby interfering with the...
Catalog:
MRRPB5
January 2023
Price: USD 2,900.00
As an extension of the intelligent medicine cabinet, the intelligent medicine rack is used to store the large infusion and heterogeneous drugs that...
Catalog:
LPI
February 2023
Price: USD 3,660.00
Hypereosinophilic Syndrome - Pipeline Review, H1 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline...
Catalog:
Global Markets Direct
May 2018
Price: USD 2,000.00
As per NAVADHI Market Research, the global pharmaceutical industry will we worth USD 1.57 trillion by 2023. Amgen Inc. is an American multinational...
Catalog:
NAVADHI
June 2019
Price: USD 200.00
Biosimilars is a biological product designed to have similar active properties to the one that has been previously licensed and has no clinically...
Catalog:
LPI
February 2023
Price: USD 3,660.00
Hypereosinophilic Syndrome - Pipeline Review, H2 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline...
Catalog:
Global Markets Direct
November 2018
Price: USD 2,000.00
Biosimilars is a biological product designed to have similar active properties to the one that has been previously licensed and has no clinically...
Catalog:
MRRPB5
February 2023
Price: USD 2,900.00
Angina (Angina Pectoris) - Pipeline Review, H2 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide...
Catalog:
Global Markets Direct
September 2018
Price: USD 2,000.00
Angina (Angina Pectoris) - Pipeline Review, H1 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide...
Catalog:
Global Markets Direct
March 2018
Price: USD 2,000.00
Adenosine Receptor A3 (ADORA3) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update...
Catalog:
Global Markets Direct
July 2022
Price: USD 3,500.00
An orphan drug is a drug used to treat a disease that cannot be produced profitably without government assistance because of the small number of...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
Filter By Report Date
Filter By Industry
Filter By Country
- (-) Remove Global filter Global
- Latin America (2) Apply Latin America filter
- Middle East (2) Apply Middle East filter
- Africa (1) Apply Africa filter
- Americas (1) Apply Americas filter
- Asia (1) Apply Asia filter
- BRIC (1) Apply BRIC filter
- Caribbean (1) Apply Caribbean filter
- Oceania (1) Apply Oceania filter
